MEDINDIA
English
हिन्दी
Español
français
中文
Glenmark Pharmaceuticals has signed a partnership with SaNOtize to manufacture, market and distribute Nitric Oxide Nasal Spray (NONS) for COVID-19 treatment.
COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.
In the first 24 hours, NONS reduced the average viral load by around 95 per cent, and then by more than 99 per cent within 72 hours. It has been tested in healthy volunteers and patients as part of UK and Canada clinical trials, the Indian company said.
The nasal spray, is designed to kill the coronavirus in the upper airways, preventing it from incubating and spreading to the lungs.
Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
China Approves Phase 1 Study of COVID Vaccine Administered by Nasal Spray
COVID-19 vaccine administered through nasal spray receives approval in China for Phase I study, reports GlobalData.
COVID-19 vaccine administered through nasal spray receives approval in China for Phase I study, reports GlobalData.
Nasal Spray For Parkinson's Disease Delivers Treatment Directly To Brain
Development of a nasal spray treatment for patients with Parkinson's disease shows significant progress where the treatment is directly delivered to the brain.
Development of a nasal spray treatment for patients with Parkinson's disease shows significant progress where the treatment is directly delivered to the brain.
